The QualityStocks Daily Thursday, January 24th, 2019

Today's Top 3 StockMarketWatch

CNBC Breaking News (PCG) +74.59%

StocksToBuyNow (ASCK) +33.33%

StockMarketWatch (KZIA) +30.25%

The QualityStocks Daily Stock List

Kona Gold Solutions, Inc. (KGKG)

Stockopedia, Insider Financial, YCharts, Stockwatch, Dividend Investor, InvestorsHub, MarketWatch, OTC Markets, Barchart, 4-Traders, Investors Hangout, Information Vine, Penny Stock Tweets, The Street, Business Insider, SmallCapVoice, Simply Wall St, SmallCapExclusive, EmergingGrowth, MicroCapDaily, and PinkInvesting reported on Kona Gold Solutions, Inc. (KGKG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kona Gold Solutions, Inc. is a hemp lifestyle brand centered on product development in the functional beverage sector. It has developed a premium Hemp Infused Energy Drink line, Energy shots, and Apparel. Kona Gold is a member of the Hemp Industries Association (HIA). The Company lists on the OTC Markets.

Its wholly-owned subsidiaries are Kona Gold, LLC; HighDrate, LLC; and BitHive Mining, LLC. Kona Gold is in the process of selling its subsidiary BitHive Mining to a private company as it leaves the cryptocurrency market to concentrate on its core beverage business.

Kona’s HighDrate subsidiary has developed the beverage industry’s first CBD Energy Water. It is available in four flavors – Watermelon, Kiwi Strawberry, Tropical Coconut, and Georgia Peach. This subsidiary’s focus is on consumers that lead an active lifestyle and require a balanced beverage, which will meet their needs of providing their mind and body with a focused boost and quick recovery.

Kona Gold Solutions announced this past May two new distribution deals in Bermuda and New York.  The Bermuda distribution deal marks Kona’s first distribution partner outside of the United States. The partner will be exclusively distributing Kona Gold Hemp Energy Drinks on the island of Bermuda.  The Company’s new distribution partner in Upstate New York will be distributing Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters.

Recently, Kona Gold Solutions announced it secured a new distribution partner in San Diego, California.  California High Beverages will be distributing Kona Gold Hemp Energy Drinks in San Diego and the surrounding areas.

In addition, the Company announced its move into Massachusetts through securing a new distribution partner in Marston Mills.  The Marston Mills distributor will be distributing the Company’s Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters. Also, Kona Gold announced it will be producing its premium Hemp Energy Drinks in new, slim line 12 oz. printed cans to meet customer demand.

Kona Gold Solutions, Inc. (KGKG), closed Thursday's trading session at $0.0578, up 2.85%, on 5,373,080 volume with 219 trades. The average volume for the last 3 months is 8,173,047 and the stock's 52-week low/high is $0.0072/$0.125.

chart

Emblem Corp. (EMMBF)

TipRanks, Insider Financial, Micro Cap Research, 4-Traders, Marijuana Stocks, The Street, Penny Stock Tweets, Daily Marijuana Observer, CannabisNewsBreaks, Profit Confidential, Stockhouse, New Cannabis Ventures, Stockwatch, Proactive Investors, InvestorsHub, WalletInvestor, PotNetwork, and Cannabis Stock Picks reported on Emblem Corp. (EMMBF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Emblem Corp., by way of its wholly-owned subsidiary, Emblem Cannabis Corporation, is a fully integrated LP (Licensed Producer) and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). The Company has three distinct verticals. These are cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem is headquartered in Toronto, Ontario and lists on the OTC Markets.

The Company’s three businesses cover the full cannabis spectrum. This is from growing, to selling, to educating, to creating new forms of cannabinoid-based medication in standardized dosages.

Emblem has its Paris, Ontario facility. The new Paris facility was custom-designed and purpose-built specifically to cultivate and cure cannabis for medicinal use. This facility has a planned expansion to 17,000KG of annual production.

Emblem Cannabis is a team of passionate growers. Their dedication is to cultivating cannabis strains in their purest expression.

Furthermore, the Company has its Emblem Pharmaceutical. Mr. John Stewart, Chief Executive Officer of the Emblem Pharmaceutical Division, said, “…Emblem is identifying the cannabis strains with the greatest evidence of benefit in various conditions, cultivating those strains at medical grade and developing advanced dosage forms to provide patients with accurate, consistent, high quality and convenient to use cannabis formulations.”

Emblem also has its GrowWise Health division. GrowWise’s dedication is to providing patients and physicians with complimentary, personalized, education services to make informed decisions regarding medical cannabis treatment options.

Recently, Emblem announced that it signed a non-binding Letter of Intent (LOI) to acquire all of the issued and outstanding securities in Natura Naturals, Inc., which the Company does not already own, for $25 million in cash, $12.5 million in mortgage financing and 26,102,941 common shares of Emblem. Upon completion of the Transaction, Emblem will further its aggressive approach to sales growth domestically and globally backed by strong supply from the Natura greenhouse.

Natura Naturals (Leamington, Ontario) is a licensed cultivator of medical cannabis pursuant to Health Canada's ACMPR. Natura operates a 662,000 sq. ft. licensed greenhouse. It is now undergoing a phased conversion and retrofit, which is expected to bring up to 15,000 kg of annualized cannabis production online this year. Upon completion in 2019, the expectation is that the facility will bring total annualized cannabis production capacity to around 70,000 kg per year.

Recently, Emblem and GreenSpace Brands announced a strategic partnership to develop and commercialize cannabidiol (CBD) infused health and beauty products for the expected adult-use cannabis market. The pioneering partnership unites a highly-regarded Consumer Packaged Goods (CPG) company with one of Canada’s most trusted licensed producers of medical cannabis.

This partnership will take advantage of GreenSpace’s expertise in consumer brand development and distribution to launch products infused with Emblem’s CBD extracts across several verticals. Each approved product will indicate it is “Powered by Emblem” to signify Emblem’s involvement.

Emblem Corp. (EMMBF), closed Thursday's trading session at $0.95, up 5.56%, on 345,291 volume with 216 trades. The average volume for the last 3 months is 227,509 and the stock's 52-week low/high is $0.603/$1.89.

chart

Northstar Electronics, Inc. (NEIK)

Front Page Stocks, MarketWatch, Stockhouse, Marketwired, and OTC Watch reported on Northstar Electronics, Inc. (NEIK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Northstar Electronics, Inc. is working in the aviation, defense, and marine industries. The Company has an extensive history of developing and manufacturing defense and commercial electronic and mechanical systems. Northstar Electronics has its corporate office in Virginia Beach, Virginia. The Company lists on the OTC Markets Group’s OTCQB.

Northstar established in the late 1990’s. It carried out design and manufacturing contracts for different divisions of Lockheed Martin Corp. In addition, it designed, manufactured, and sold its own sonar-based system to commercial customers.

Northstar has moved towards making and selling its own independent systems, since the termination of the aforementioned contracts. At present, the Company is undergoing restructuring to move forward with a renewed emphasis on the development of a new aviation business and also carry out work to develop unique sonar systems.

Northstar Electronics’ subsidiary is Northstar Sealand Enterprises Ltd. (NSEL). Subsidiary NSEL is jointly owned by Northstar Electronics and Sealand Aviation Ltd.  Both companies have many years of experience in working with certified commercial aircraft and government military contracts. 

NSEL is working to acquire the worldwide rights to a “Turbo-Prop” single engine industrial airplane from an international leader in the aerospace industry. The timeline for the final agreement with the subsidiary company that owns the rights to the airplane has been extended.

The main applications for the airplane are in “Agriculture and Rapid Response Forest Fire Fighting (RRFFF).” NSEL is continuing its evaluation of the “Cloud Seeding” market. Company Management believes the new design features of the NSEL airplane will quickly lead to it being a leader in its class.

Upon the signing of the airplane “Rights Acquisition Agreement”, NSEL’s intention is to launch its plans to start the actions leading to manufacturing the airplane and marketing it around the world.

Work is advancing on the prototype aircraft, planned to be flying and certified next year. NSEL is finalizing arrangements to assemble, certify, manufacture, service, repair, and market a new turboprop single engine commercial aircraft in Canada, for the global market, beginning at first with the North, South, & Central American markets.

Northstar Electronics also sees major potential in the field of Counter Insurgency (COIN). Company Management is exploring future possibilities in this sector.

Northstar Electronics, Inc. (NEIK), closed Thursday's trading session at $0.00984, up 9.94%, on 76,100 volume with 9 trades. The average volume for the last 3 months is 19,902 and the stock's 52-week low/high is $0.0052/$0.0149.

chart

Sport Endurance, Inc. (SENZ)

Stock Traders Chat, StockMister, 24-7 Stock Alert, HotOTC, Simply Best Penny Stocks, Top Best Pennystocks, BullRally, Global Equity Report, CoolPennyStocks, Promotion Stock Secrets, Stock Beast, StockRockandRoll, Open Water Investments, OTC Picks, Penny Invest, Stock Rich, StockEgg and Penny Stock Explosion reported on Sport Endurance, Inc. (SENZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sport Endurance, Inc. develops, markets, and distributes nutritional supplement products throughout the U.S. Its goal is to improve health through providing quality and effective nutritional supplements. All Sport Endurance brand products are manufactured in the U.S. in Food and Drug Administration (FDA)-inspected facilities with strict quality control that follows Good Manufacturing Practices (GMP). Sport Endurance has its head office in Jersey City, New Jersey.

The Company’s supplements are natural supplements and contain no ingredients that would require a prescription. The all-natural dietary supplements meet wellness needs without using harsh synthetic chemicals.

Regarding nutritional supplement products, Sport Endurance’s primary emphasis is on three areas of health that most directly affect the lives of many active adults. These are Total Wellness, Performance, and Recovery. The Company has launched its website to market men’s health products direct to consumers. 

Additionally, the Company has created a cryptocurrency lending subsidiary. Yield Endurance (a wholly-owned subsidiary) is its newly established cryptocurrency lending subsidiary. Yield Endurance offers institutional investors a lending program for their cryptocurrency assets.

Through, Yield Endurance, and its strategic agreement with Madison Partners, Sport Endurance is centered on increasing liquidity and institutional participation in the cryptocurrency markets through providing institutional investors, through Madison Partners, the ability to borrow, hedge, and arbitrage cryptocurrencies that trade on the various cryptocurrency exchanges.

This includes Bitcoin, Bitcoin Cash, Ethereum and Litecoin. Madison Partners is a registered Money Services Business. Its focus is on providing counter parties with over the counter liquidity and block trading services.

Recently, Sport Endurance’s subsidiary, Yield Endurance, announced that its strategic business partner, Madison Partners, extended a loan of 100 Bitcoins under the Digital Asset Lending Program created by Yield and Madison.

Mr. David Lelong, Chief Executive Officer of Sport Endurance and Yield Endurance, stated, “We are pleased to report that our strategic partner has executed a new bitcoin loan with another institutional investor. In a primarily retail driven market, our institutional-focused Digital Asset Lending Program will increase liquidity, help support an orderly trading environment for cryptocurrency, and encourage institutional participation in the crypto market. We look forward to continuing our build out of portfolio clients and inventory of loanable cryptocurrency assets.”

Sport Endurance, Inc. (SENZ), closed Thursday's trading session at $0.121, down 2.02%, on 21,000 volume with 4 trades. The average volume for the last 3 months is 20,760 and the stock's 52-week low/high is $0.07/$1.20.

chart

Golden Predator Mining Corp. (NTGSF)

Penny Stock Hub, Stockhouse, Gold Investment Letter, Junior Mining Network, 4-Traders, Mining Stock Valuator, Morningstar, Market Screener, OTC Markets, Barchart, The Street, Investors Hangout, and Dividend Investor reported earlier on Golden Predator Mining Corp. (NTGSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Golden Predator Mining Corp. acquires and explores for mineral properties in the U.S. and Canada. The OTCQX-listed Company focuses on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. The Company previously went by the name Northern Tiger Resources, Inc. It changed its name to Golden Predator Mining Corp. in April of 2014. Golden Predator Mining is based in Vancouver, British Columbia.

The 3 Aces Project hosts the two highest grade surface outcrops discovered to date in the Yukon. The 100 percent owned 3 Aces Project is 357 km2 (35,700 hectares). It is a high-grade gold project (Orogenic Gold Model). The 3 Aces Project includes at least 6 mineralized areas. These are all positioned within and along favorable stratigraphic and structural zones, which extend greater than 35km along trend. A number of mineralized veins have been discovered so far. Many have visible gold occurrences.

In addition, Golden Predator Mining holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by the Company. The target at the Brewery Creek Mine is an intrusion related gold deposit. The Brewery Creek Mine is 55km east of Dawson in the northwestern area of the Yukon.

This week, Golden Predator Mining announced results of the 2018 drill program in the Central Core Area at the 3 Aces Project in southeast Yukon that was completed to test for extensions of the high grade structures outcropping in the Hearts Zone. Seven HQ diamond drill holes consistently intercepted two parallel, closely spaced gold-bearing structures along 220m of strike and 500m down dip from the Hearts discovery outcrop. This was the deepest drilling so far on the project. The structures in the Hearts Zone continue to be open in all directions along strike and at depth.

Golden Predator Mining Executive Chairman, Mr. William Sheriff, said, “Confirming the continuity and mineralization of the structures down dip and on strike, right where we projected them to be, is a game-changer in terms of demonstrating the size potential of the 3 Aces Project. It is now clear that the high grade surface outcrops previously discovered in the Central Core Area are not isolated occurrences but rather expressions of a much larger system, which significantly expands the potential at 3 Aces.”

Golden Predator Mining Corp. (NTGSF), closed Thursday's trading session at $0.206, down 5.33%, on 23,200 volume with 20 trades. The average volume for the last 3 months is 54,586 and the stock's 52-week low/high is $0.1494/$0.644.

chart

Dakota Territory Resource Corp. (DTRC)

InvestorsHub, Zacks, Market Screener, YCharts, TradingView, Stockhouse, Barchart, Simply Wall St, Uptick Newswire, Real Investment Advice, Innovative Marketing, OTC Markets Group, Ultimate Penny Stock, MarketWatch, The Street, Marketbeat, Dividend Investor, last19k, Wallet Investor, Corporate Information, and 4-Traders reported earlier on Dakota Territory Resource Corp. (DTRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dakota Territory Resource Corp.’s emphasis is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three gold properties encompassing roughly 4,059 acres. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these properties are in the heart of the Homestake District. OTCQB-listed, Dakota Territory Resource is headquartered in Reno, Nevada.

The Company’s flagship property is the Blind Gold Property, which is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is about four miles northwest and on structural trend with the historic Homestake Gold Mine.

The Homestake Gold Mine produced roughly 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.

Dakota Territory’s plan is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. The program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne.

The Homestake Paleoplacer Property consists of 13 unpatented lode mining claims. These are situated one-mile north of the Homestake Open Cut. Dakota based the acquisition of its Black Hills property position on more than 44 years of combined mining and exploration experience in the Homestake District.

The Company’s City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims. These are positioned one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.

This week, Dakota Territory Resource announced the appointment of Mr. Lee Graber to the Company’s Strategic Advisory Committee. Mr. Graber has more than four decades of experience in the mining industry. This includes 23 years with Homestake Mining Company, one of the largest gold mining companies in the U.S. until it was acquired in 2002 by Barrick Gold Corporation.

As Homestake's Vice President responsible for corporate development, Mr. Graber initiated, managed, and closed manifold joint venture agreements, major acquisitions, and divestment transactions. After Homestake, Mr. Graber served as Managing Director, Mergers and Acquisitions, for Endeavour Financial Ltd.

Dakota Territory Resource Corp. (DTRC), closed Thursday's trading session at $0.055, down 31.25%, on 627,228 volume with 26 trades. The average volume for the last 3 months is 35,370 and the stock's 52-week low/high is $0.0251/$0.15.

chart

Anvia Holdings Corporation (ANVV)

High Rising Stocks, Jet Life Penny Stocks, Stockopedia, Barchart, Stockhouse, Simply Wall St, Wallmine, Investors Hangout, Street Insider, Stock Orange, OTC Markets, 4-Traders, GuruFocus, Stockwatch, Penny Stock Hub, Morningstar, and TradingView reported earlier on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Anvia Holdings Corporation is an international technology company that creates comprehensive, turnkey software and consulting solutions for small to medium-sized businesses. The Company is also the world’s complete eco-system for tradesmen in the construction industry. Its businesses serve the complete lifecycle of tradesmen or handymen in the construction industry. Anvia works to build competent tradesmen for the construction industry and make them accessible to the market. The Company has its corporate office in Glendale, California.

Anvia is the first integrated platform for blue-collar workers in the construction industry to provide qualification, licensing, continuous education, placement services, entrepreneurship opportunities, and cash-back or loyalty programs in Australia and globally. The Company has its Anvia College. This College offers quality and world-class education services and products to its aspiring tradesmen and construction workers in a blended learning environment. Anvia College provides essential qualification courses related to the construction environment.

In addition, Anvia offers its Anvia Loyalty. This is a free loyalty program by the Company designed for existing qualified and aspiring tradesmen. Anvia Loyalty is a single platform. It connects the Company’s members to all Anvia products and services.

The Company also has its Anvia Recruiters. Anvia Recruiters provides employment services to graduates of Anvia College and Anvia members around the world. Furthermore, the Company has its Anvia Market. Anvia market is an online store for tradesmen or handymen involved in the construction industry to buy safety wear and tools.

In May 2018, Anvia Holdings announced that it fully acquired Anvia (Australia) Pty Ltd, previously known as Kasa Corporation (Australia) Pty Ltd. Anvia (Australia) Pty Ltd is a fully-owned subsidiary of Anvia Holdings. Anvia Australia commercializes Anvia’s intellectual property (IP) assets. These assets include Anvia Learning, Anvia Market, Anvia Recruiters and Anvia Loyalty in the Australian Market.

At the end of December 2018, Anvia Holdings announced that it signed a definitive agreement to acquire all of the issued and outstanding shares of Workstar Technologies Pty Ltd. This is an Australian corporate training and development institution, trading under the brand Workstar. With this agreement, Anvia Holdings, via its fully owned subsidiary Anvia (Australia) Pty Ltd, will acquire 100 percent of Workstar Technologies Pty Ltd outstanding shares for USD 216,000 (AUD 300,000). Workstar offers tailored digital content and corporate learning to major Australian and international companies.

This month, Anvia Holdings announced that it signed a definitive agreement to acquire all of the issued and outstanding shares of All Crescent Sdn Bhd. This is a Malaysian company with technology assets including learning management systems, digital content and exclusive licenses with government funding for semiconductor industry technical training.

Anvia Holdings Chief Executive Officer, Ali Kasa, said, “having All Crescent and its subsidiaries as part of our group helps increase our customer base, consolidate our technology assets and lower our operating cost.”   

Anvia Holdings Corporation (ANVV), closed Thursday's trading session at $0.81, down 4.71%, on 500 volume with 1 trade. The average volume for the last 3 months is 1,391 and the stock's 52-week low/high is $0.51/$1.70.

chart

Regulus Therapeutics, Inc. (RGLS)

Investor Network, Zacks, 4-Traders, Stock Twits, Stock News Gazette, Simply Wall St, YCharts, InvestorsHub, MarketWatch, Stockhouse, Nasdaq, and The Street reported earlier on Regulus Therapeutics, Inc. (RGLS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Regulus Therapeutics, Inc. is leading the discovery and development of innovative medicines targeting microRNAs. The Company is advancing several programs in renal, hepatic and central nervous systems (CNS) diseases. A clinical stage biopharmaceutical enterprise, Regulus Therapeutics was established in September 2007 by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, now Ionis Pharmaceuticals (IONS). Regulus Therapeutics is headquartered in La Jolla, California.

Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline. This pipeline is complemented by a rich intellectual property (IP) estate. Together, this enables the Company to retain its leadership in the microRNA field.

Regulus Therapeutics has its RG-012 for Alport syndrome and RGLS4326 for autosomal dominant polycystic kidney disease (ADPKD). Alport syndrome is an inherited form of kidney disease. RG-012 is undergoing development by Regulus in a strategic alliance with Genzyme, a Sanofi company, for the treatment of Alport syndrome.

RG-012 is a single stranded, chemically modified oligonucleotide. It binds to and inhibits the function of miR-21 for the treatment of Alport syndrome. ADPKD is among the most common human monogenetic disorders. In addition, it is a leading genetic cause of end-stage renal disease. RGLS4326 is a novel oligonucleotide. The design of it is to inhibit miR-17 using an inventive chemistry design to preferentially target the kidney.

Regulus and STA Pharmaceutical Co., Ltd. (STA) entered into an oligonucleotide synthesis collaboration agreement in 2018 for research and mid-scale non-GMP/cGMP manufacturing. STA is a WuXi AppTec group company. It is the foremost open-access capability and technology platform for small molecule pharmaceutical development and manufacturing.

Earlier this month, Regulus Therapeutics announced the nomination of RGLS5579 as a clinical candidate for the treatment of glioblastoma multiforme (GBM). RGLS5579 is a novel oligonucleotide. The design of it is to inhibit miR-10b. Preclinical studies with RGLS5579 have demonstrated direct anti-tumor effects in vitro and in vivo.

Mr. Jay Hagan, President and Chief Executive Officer of Regulus Therapeutics, said, "We are excited to announce our clinical candidate for the treatment of GBM, a devastating form of brain cancer, for which therapeutic options are extremely limited. The combination data we have generated, and repeated, may suggest that we can significantly extend expectations for survival for patients with GBM over the current standard of care."

Regulus Therapeutics, Inc. (RGLS), closed Thursday's trading session at $0.935, down 2.55%, on 183,888 volume with 538 trades. The average volume for the last 3 months is 310,159 and the stock's 52-week low/high is $0.80/$16.68.

chart

Kalytera Therapeutics, Inc. (KALTF)

Penny Stock Hub, Dividend Investor, Proactive Investors, YCharts, Capital Network, OTC.Watch, Investing, The Street, OTC Markets, InvestorsHub, 4-Traders, Stockhouse, Stockwatch, Marketbeat, Investors Hangout, and Barchart reported earlier on Kalytera Therapeutics, Inc. (KALTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kalytera Therapeutics, Inc. is pioneering the development of a next generation of cannabinoid therapeutics. The Company is working to establish a leading position in the development of novel cannabinoid medicines for an array of important unmet medical needs, with an initial focus on Graft versus Host Disease (GvHD). Kalytera Therapeutics has its U.S. headquarters in Novato, California. A clinical-stage pharmaceutical company, its research facility is in Israel.

Kalytera Therapeutics is also developing a new class of proprietary cannabidiol (CBD) therapeutics. Its intention is to explore the use of CBD, a non-psychoactive cannabis constituent. The Company is working to advance a portfolio of synthetic, non-psychoactive cannabis-like molecules. Additionally, Kalytera will center on orphan conditions, with the aim of generating data in humans that may support follow-on studies in major conditions.

Kalytera received approval from the Institutional Review Board (IRB) at one of two clinical sites in Israel. This is to begin a Phase 2 study to evaluate cannabidiol (CBD) for the prevention of GvHD. The proposed study is a Phase 2, open label, multicenter trial. The trial is to evaluate the pharmacokinetic profile, safety, and efficacy of numerous doses of CBD for the prevention of GvHD following allogeneic hematopoietic cell transplantation (HCT). The proposed study will take place at the Rabin Medical Center, Beilinson, and the Rambam Health Care Campus, Haifa, in Israel.

The expectation is that Kalytera’s continuing Phase 2b clinical study evaluating the use of CBD in the prevention of GVHD will be completed early this year. Upon completion of the Phase 2b clinical study, Kalytera will begin preparations for the pivotal Phase 3 clinical study that will be required for Food and Drug Administration (FDA) approval.

The work that Kalytera Therapeutics is doing in GVHD consists of two separate product development programs. One is a program evaluating CBD for the prevention of acute GVHD. A separate program is evaluating CBD for the treatment of acute GVHD. The Company’s program in prevention of acute GVHD is more advanced than is the program in treatment of acute GVHD.

Kalytera Therapeutics is the exclusive licensee of two issued U.S. patents covering the use of CBD in the prevention and treatment of GVHD. It is also the exclusive licensee of pending patent applications in other jurisdictions for the use of CBD in the prevention and treatment of GVHD.

Recently, Kalytera Therapeutics announced positive interim data from its continuing Phase 2 clinical study evaluating cannabidiol (CBD) for the prevention of acute graft versus host disease (GVHD) following bone marrow transplant. Interim data from the initial 12-patient cohort support the following key findings to date.

No patients receiving oral CBD at the lowest study dose of 75 mg twice daily (BID) have developed grades 3 or 4 acute GVHD. One patient developed grade 2 acute GVHD, the least serious form of the disease. CBD has demonstrated a good safety and tolerability profile, with no significant adverse events relating to its use.

Kalytera Therapeutics, Inc. (KALTF), closed Thursday's trading session at $0.0588, down 9.40%, on 78,350 volume with 10 trades. The average volume for the last 3 months is 213,068 and the stock's 52-week low/high is $0.0361/$0.3187.

chart

Mentor Capital, Inc. (MNTR)

Stock Profile, Promotion Stock Secrets, Laissez Faire Today, BUYINS.NET, Stocks That Move, Wealth Insider Alert, Market Intelligence Center Alert, InvestorsUnderground, Cancer Roll Up Strategy, Stockgoodies, StreetAuthority Daily, and Five Star Stock Picks reported on Mentor Capital, Inc. (MNTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis arena. It looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial objectives, to add protection for investors, and to help incubate private cannabis companies. Mentor Capital has its corporate office in San Diego, California.

The Company takes a major position in the varied members of its portfolio of participating companies. However, it leaves operating control in the hands of the cannabis company founders.

Mentor participates in the legal recreational marijuana market. Nonetheless, its favored focus is medical. It looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma, in addition to reducing chronic pain.

Mentor’s preferred involvement is with larger and private pre-IPO (Initial Public Offering) medical marijuana companies that it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity. Mentor Capital transferred to the cannabis space from front-line cancer investments.

In February of this year, Mentor Capital announced that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor Capital stated it would be pleased to make a series of cannabis centered investments with cannabis veteran and Pueblo Founder, Pat Leonard.

Mentor Capital has set up Mentor Partner II, LLC as a channel for this purpose. The initial investment is roughly $400,000 lease of a system for supercritical extraction.

Recently, Mentor Capital started to trade on the OTCQX Best Market. The Company joins greater than 20 companies during 2018 that have upgraded to OTCQX from the OTCQB® Venture Market, according to OTC Markets Group, Inc.

Mr. Chet Billingsley, Mentor Capital’s Chairman and Chief Executive Officer, said, "We are delighted to be moving up to OTCQX. When we shifted to the medical marijuana market in 2013, we committed to bring professionalism and integrity to the cannabis sector like we had encountered both in Silicon Valley and while working in cancer-related biotech outside of San Diego, which we feel is signaled by this move to OTC Market’s top tier. Those high standards also link to a tangible investor advantage. Accordingly, this upgrade is a significant milestone for Mentor Capital, and we believe a step towards increasing the liquidity of our stock."

Mentor Capital, Inc. (MNTR), closed Thursday's trading session at $0.47, up 3.88%, on 49,072 volume with 50 trades. The average volume for the last 3 months is 76,891 and the stock's 52-week low/high is $0.30/$1.95.

chart

biOasis Technologies, Inc. (BIOAF)

Zacks, Stockwatch, SmallCapFinancialWire, OTC Markets Group, VentureBeat, and PennyStocks24 reported on biOasis Technologies, Inc. (BIOAF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

biOasis Technologies, Inc. concentrates on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). It is developing and commercializing the xB3 platform, its proprietary blood-brain barrier delivery technology, to address unmet medical needs in the treatment of central nervous system (CNS) diseases and disorders. A biopharmaceutical enterprise, biOasis Technologies has its corporate office in Richmond, British Columbia.

The delivery of therapeutics across the BBB represents the single greatest challenge in treating neurological disorders. The Company’s Transcend Platform consists of a diverse set of peptide carriers and linkers. These, together, provide transport solutions for an array of CNS therapeutics. These include monoclonal antibodies, enzymes, small molecules, and different kinds of gene therapies.

Transcend was discovered in the 1990’s in Dr. Wilfred Jefferies’s laboratory at the Michael Smith Laboratories at The University of British Columbia. Transcend is based on the naturally occurring human transport protein, melanotransferrin, also called MTf, CD228 and p97. MTf is found at low concentrations in the blood.

MTf is able to cross the BBB through a process called Receptor Mediated Transcytosis where MTf molecules attach to receptors on the cells of the BBB and is subsequently pulled through the cells and into the brain. With biOasis’ proprietary Transcend carrier, the MTf protein can be attached to therapeutics of different sizes and kinds.

The Transcend Platform is currently available to be licensed by biotechnology and pharmaceutical companies for the advancement of their neurotherapeutic programs. The Transcend Platform has attained a significant high level of success in dozens of studies at more than 20 third-party institutions and pharmaceutical companies. biOasis Technologies has acquired full patent protection for its Transcend group of peptide carriers and linkers.

The Transcend-peptide platform is now referred to as the xB3 platform. It is part of biOasis’ patented portfolio that is transforming therapeutic brain-drug delivery.

Last month, BiOasis Technologies and BioAgilytix announced a strategic collaboration to partner on the development and validation of bioanalytical methods to support and advance the xB3 TM-001 program, BiOasis’ lead candidate to treat HER2+ brain cancer, to investigational new drug (IND) submission and into the clinic. BioAgilytix is a foremost provider of contract bioanalytical testing services with a specialization in large molecule bioanalysis.

Via this partnership, BiOasis Technologies will have access to BioAgilytix’s extensive bioanalytical expertise, especially in ligand binding assays, anti-drug antibody detection, stability assessments across complex matrices and highest quality GLP validation of complex assays.

Recently, BiOasis Technologies announced positive results from a Microdialysis Study showing lead investigational candidate xB3 ™-001 increased brain activity. The Company conducted the Microdialysis Study at Charles River Laboratories, Inc.

The goal of the study was to evaluate the effect of xB3-001 on cortical brain-related activity in a freely-moving in vivo mouse Microdialysis Study. Brain activity was assessed by examining changes on neurochemical levels induced by biOasis’ lead candidate xB3-001 in comparison to trastuzumab alone. This study demonstrated that following a single intravenous treatment, xB3-001 elicited considerable increases in brain cortical dopamine and serotonin activity levels at 60-90 minutes after treatment.

biOasis Technologies, Inc. (BIOAF), closed Thursday's trading session at $0.336045, up 4.04%, on 6,500 volume with 4 trades. The average volume for the last 3 months is 13,404 and the stock's 52-week low/high is $0.2096/$0.7435.

chart

Bionik Laboratories Corp. (BNKL)

NetworkNewsWire, Marketbeat, OTC Markets, InvestorsHub, Stockhouse, Street Insider, Barchart, Market Exclusive, Zacks, MarketWatch, 4-Traders, Equities, and Wallet Investor reported earlier on Bionik Laboratories Corp. (BNKL), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Bionik Laboratories Corp. is a robotics company centered on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. Through the acquisition of Interactive Motion Technologies, the Company has added a portfolio of products focused on upper and lower extremity rehabilitation of stroke patients and other mobility-impaired patients.

Bionik Laboratories fully integrated Interactive Motion Technologies, Inc. into the Company following the May 2016 acquisition. OTCQB-listed, Bionik Laboratories is headquartered in Toronto, Ontario. The Company has its U.S. headquarters in Watertown, Massachusetts.

Bionik Laboratories has three products available on the market and four products in different stages of development. The design of the InMotion Systems - the InMotion ARM™, InMotion HAND™, InMotion ANKLE™, and InMotion WRIST™ are to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neuro-recovery.

The InMotion ARM is an evidence based intelligent, interactive rehabilitation technology. It senses patient movements and limitations, providing assistance-as-needed™ in real-time. The InMotion HAND is an add-on module to be used with the InMotion ARM™. The two work together to provide assist-as-needed™ support for reaching with grasp and release movements, or independently for focused training on individual hand movements.

Furthermore, Bionik has launched the next-generation InMotion™ Arm. It launched its next-generation InMotion Arm interactive robotic system for the clinical rehabilitation of stroke survivors and those with mobility impairments because of neurological conditions. The improved new generation InMotion Arm will provide the same inventive active-assisted robotic therapy.

InMotion WRIST is an evidence based and research proven interactive rehabilitation device. InMotion WRIST senses patient movements and limitations. Additionally, it provides assistance-as-needed™. It can accommodate the range of motion of a normal wrist in daily tasks. InMotion WRIST can be used by clinicians as a stand-alone treatment option or in addition to the InMotion ARM.

The Company is also developing a lower-body exoskeleton, ARKE™. The design of ARKE™ is to allow paraplegics and other wheelchair users the ability to rehabilitate through walking.

Yesterday, Bionik Laboratories announced the commercial launch of its newest generation InMotion ARM/HAND™ robotic system. Bionik is showcasing the new technology for the first time at its booth (#736) at the American Physical Therapy Association Combined Sections Meeting (APTA CSM) taking place January 23-26, 2019 at the Walter E. Washington Convention Center in Washington, D.C.

Dr. Eric Dusseux, Bionik Laboratories’ Chief Executive Officer, said, “The goal of our new generation InMotion ARM/HAND is to enable rehabilitation facilities to enhance their treatment programs for patients recovering from stroke or other neurological injury who are ready to retrain reach and grasp functionality. Along with the improved reporting capabilities, we believe our innovative technology will enable clinicians to improve the patient rehabilitation process and achieve greater recovery for stroke survivors.”

Bionik Laboratories Corp. (BNKL), closed Thursday's trading session at $6.00, down 7.69%, on 490 volume with 4 trades. The average volume for the last 3 months is 18,748 and the stock's 52-week low/high is $1.00/$24.75.

chart

Flux Power Holdings, Inc. (FLUX)

Tip.us, Catalyst IR, Penny Stock Pick Alert, Penny Stock Pick Report, StockMister, PennyPickAlerts, Joe Penny Stocks, Liquid Tycoon, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks, Winning Penny Stock Picks, The Wall Street Transcript, Stock News Now, PennyStocks24, PennyStockMoneyTrain, Rising Penny Stocks, Lebed, Wall Street Grand, and Greenbackers reported previously on Flux Power Holdings, Inc. (FLUX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Flux Power Holdings, Inc. is a developer of advanced lithium batteries for industrial applications. This includes its first-ever UL 2271 Listed lithium-ion "LiFT Pack" forklift batteries. The Company develops and markets advanced lithium-ion energy storage systems (batteries) based on its proprietary battery management system (BMS) and in-house engineering and product design. Flux Power Holdings has its corporate office in Vista, California. The Company lists on the OTC Markets’ OTCQB.

Flux Power’s storage solutions deliver improved performance, extended cycle life, and greater return on investment (ROI) than legacy solutions. The Company’s products include advanced battery packs for motive power in the lift equipment, tug and tow, and robotics markets, portable power for military applications, and stationary power for grid storage. Applications include Motive Power, Portable Power, and Stationary Power. Motive Power includes Lift Pack - Class III Walkie Trucks and Lift Pack - Tug & Tow Pack.

Pertaining to the Flux battery model: LiFT-24V, it offers up to a 5 times longer lifespan and up to a 25 percent longer run time. Moreover, it offers higher sustained power during every work shift. It is maintenance-free and fewer batteries are needed for multi-shift applications.

Regarding Portable Power, Flux Portable Packs consist of lithium-ion battery cells, which are managed and operated by its proprietary Battery Management System (BMS), all contained in lightweight, strong, and easily maneuvered cases. The design of the Company’s LiFT Pack solution is for walkie pallet jack forklifts, widely used in warehouses and depots, on trucks, and at retail locations.

Flux Power Holdings has developed a 72 volt, 400 Ah battery pack to power electric aviation ground support equipment, initially baggage tow tractors using the same proprietary technology found on the LiFT Pack line for small forklifts.

Recently, Flux Power Holdings highlighted continuing progress in the development and commercialization of its LiFT Pack lithium-ion batteries for industrial applications. This includes electric forklifts and airport ground support equipment (GSE).

The Company completed initial shipments of its new, more powerful LiFT Pack solutions for Class 1 counterbalance trucks during the current Q2’19 quarter ending December 31, 2018. Flux Power expects Q2’19 revenue to surpass its Q1’19 revenue of $1.8M (and prior year Q2’18 revenue of $1.2M). The Company is on course to at least double revenue in fiscal 2019 in comparison to fiscal 2018 revenue of $4.1M and fiscal 2017 revenue of $0.9M.

Flux Power Holdings, Inc. (FLUX), closed Thursday's trading session at $1.45, up 16.00%, on 1,030 volume with 5 trades. The average volume for the last 3 months is 2,019 and the stock's 52-week low/high is $0.395/$3.349.

chart

AdvanSource Biomaterials Corp. (ASNB)

Amigo Bulls, Penny Stock Tweets, Marketbeat, Stockwatch, The Street, Stockhouse, Zacks, CapitalCube, YCharts, Wallet Investor, last10k, TradingView, OTC Markets, Penny Stock Picks, and VentureLine reported previously on AdvanSource Biomaterials Corp. (ASNB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AdvanSource Biomaterials Corp. is an ISO certified materials technology company headquartered in Wilmington, Massachusetts. Specialists in polyurethane technologies, the Company provides a variety of material formats for use in long and short-term implants and disposable products. Fundamentally, AdvanSource is a foremost developer of advanced polymer materials for a wide spectrum of medical devices.

AdvanSource Biomaterials lists on the OTC Markets’ OTCQB. The Company formerly went by the name CardioTech International, Inc. It changed its name to AdvanSource Biomaterials Corp. in October of 2008.

The Company serves the medical device and pharmaceutical market. AdvanSource’s materials have a history of use in short and long-term implant applications. These include stents, artificial heart valves, VADs, catheters, guidewires, and introducers.

AdvanSource Biomaterials’ expertise lies in the synthesis and formulation of polymeric materials with a broad array of physical and chemical properties. These materials possess innovative characteristics including biocompatibility and biodurability. They can be tailored for specific properties, including lubricity and antimicrobial formats.

The Company’s biomaterials are used in devices designed for treating a wide spectrum of anatomical sites and disease states. Products include ChronoFlex AL; ChronoFlex AR; ChronoFlex C; ChronoPrene; ChronoSil; ChronoThane P; ChronoThane T; HydroMed; HydroThane; and PolyBlend.

ChronoFlex AL is a family of biodurable aliphatic polycarbonate-based thermoplastic urethanes. The design of these is to overcome surface degradation such as stress-induced microfissures.

PolyBlend is a family of very soft, aromatic polyurethane elastomeric alloys. These can be used as a substitute for natural rubber or latex in many applications. HydroMed is a series of ether-based hydrophilic urethanes with premier adhesive and cohesive properties.

Markets AdvanSource Biomaterials serves include orthopedics, cardiovascular, drug delivery, endoscopy, neurology, urology, spine, interventional radiology, peripheral vascular, ENT, gastroenterology, oncology, and diabetes management.

The Company has a strategic alliance with Medibrane Ltd. Medibrane is a top Israeli coating technology company. The Strategic Alliance provides for technology collaboration, development, and commercialization of medical coatings utilizing AdvanSource’s material technologies in collaboration with Medibrane’s coating and surface modification technologies and enhancements. Medibrane is a designer, developer and manufacturer of customized polymeric surgical implants, implantable device coatings, encapsulation coatings, as well as bio-absorbable implants.

AdvanSource Biomaterials Corp. (ASNB), closed Thursday's trading session at $0.051, up 8.51%, on 16,100 volume with 3 trades. The average volume for the last 3 months is 13,185 and the stock's 52-week low/high is $0.0281/$0.10.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Direct Selling Companies Prove Attractive for CBD Market, Drawing Large Non-Endemic Cannabis Industry Partners,” featuring Youngevity International, Inc. (NASDAQ: YGYI). To hear the CannabisNewsAudio version, visit: http://cnw.fm/vjTk7. To read the full editorial, visit: http://cnw.fm/G5spf.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.73, up 4.50%, on 117,004 volume with 630 trades. The average volume for the last 3 months is 181,819 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLSPF).

Plus Products Inc. (CSE:PLUS) is pleased to announce that the OTC Markets Group, Inc. has approved the trading of the Company’s shares on the OTCQB® Venture Market and will commence trading under the symbol “PLPRF” on January 23, 2019. The Company’s shares will continue to trade on the Canadian Securities Exchange under the symbol “PLUS”.

Plus Products Inc. (CSE: PLUS) (OTC: PLSPF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLUS), closed the day's trading session at $5.25, up 7.14%, on 85,448 volume with 103 trades. The average volume for the last 3 months is 96,943 and the stock's 52-week low/high is $3.51/$7.25.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a report published by Financialnewsmedia.com. According to a recent Forbes article, Cannabis dispensaries are a radically new retail phenomenon, selling a commodity that is still shrouded in stigma and illegal under federal law. For a Baby Boomer whose most recent cannabis transaction may have been clandestinely copping a dime bag from their neighborhood dealer some 50 years ago, visiting a dispensary can make them feel like the proverbial kid in a candy store.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.3442, off by 0.68%, on 106,584 volume with 368 trades. The average volume for the last 3 months is 167,770 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian licensed producer (“LP”) of premium cannabis products, this morning announced that it has attained approval from Health Canada to open additional grow rooms at its Kelowna 1 cultivation facility. To view the full press release, visit: http://nnw.fm/4W5aX. Also today, CannabisNewsWire released a report on the company examining how, on Tuesday last week, Gov. Albert Bryan Jr. signed a bill that legalized medical cannabis in the U.S. Virgin Islands. This brings to an end a long process that started with a referendum in favor of medical cannabis in 2014. 56.5 percent of the voters agreed that medical cannabis should be legalized and regulated.

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.70, even for the day, on 30,128 volume with 66 trades. The average volume for the last 3 months is 73,369 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) together with its wholly-owned subsidiary, TGOD Acquisition Corporation ("SpinCo"), today announced receipt of approval from the Ontario Superior Court of Justice for the previously announced plan of arrangement. Under the terms and conditions of the arrangement agreement between TGOD and SpinCo, TGOD will distribute to TGOD shareholders unit purchase warrants of SpinCo. To view the full press release, visit: http://nnw.fm/57LjZ. Also today, NetworkNewsWire released a report on the company detailing how TGODF is seeking to hasten the company’s time from harvest to sale as Health Canada assures consumers that cannabis edibles, extracts and topicals will be legal by October 2019.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.62, up 14.41%, on 1,709,224 volume with 2,239 trades. The average volume for the last 3 months is 934,498 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX), developer of a proprietary financial news media and content platform providing information to the global Chinese-speaking community, this morning announced that the company is featured in a new audio interview at SmallCapVoice.com, Inc. To listen to the full interview, visit: http://nnw.fm/u3A8W. To view the full press release, visit: http://nnw.fm/7zV4w.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.53, up 1.92%, on 89,840 volume with 66 trades. The average volume for the last 3 months is 139,668 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services (OTCQB: SHRV), a Plano, Texas-based diversified holding company, is focused on delivering exceptional support to its team of Elepreneurs, including training and mentorship initiatives. To view the full article, visit: http://nnw.fm/Wmn78.

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.2435, up 1.42%, on 53,418 volume with 7 trades. The average volume for the last 3 months is 26,996 and the stock's 52-week low/high is $0.125/$0.59.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company focused on immuno-oncology, recently reported the impending clinical use of a novel frozen formulation of the company’s lead cancer drug candidate, Bria-IMT. To view the full article, visit: http://nnw.fm/160Iu.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0663, up 0.61%, on 500 volume with 1 trade. The average volume for the last 3 months is 23,327 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks continues with part two of its series on companies targeting the global CBD pet market and what’s driving this sector. SinglePoint (OTCQB: SING), mentioned in Part 1 of the series, remains in a unique position in the emerging CBD space. As both an online marketer and payments processor, the company looks to be in a strong position to help deliver CBD products to their target markets. Also today, NetworkNewsWire released a report on the company detailing how pet owners looking for natural therapies to help their four-legged loved ones through bouts of pain and anxiety are gaining an increasing array of options as the cannabis revolution opens the doors to new product research, including therapeutics for animals. Now, SinglePoint finds itself among a competitive field that’s wild about cannabidiol (CBD) therapeutics for pets as cannabis legalization continues to advance, as noted in a report by Investorideas.com (http://nnw.fm/mLxx5).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0234, up 12.50%, on 8,205,418 volume with 338 trades. The average volume for the last 3 months is 6,006,190 and the stock's 52-week low/high is $0.0106/$0.081.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Emerging leader in the cannabis, hemp, and cannabidiol (“CBD”) marketplace Golden Developing Solutions (OTC: DVLP) this morning issued a letter to shareholders from CEO Stavros Triant. To view the full press release, visit: http://nnw.fm/LcB3H.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0205, up 3.02%, on 1,853,118 volume with 52 trades. The average volume for the last 3 months is 371,281 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News

chart

Icon Exploration Inc. (TSX.V: IEX.H)

The QualityStocks Daily Newsletter would like to spotlight Icon Exploration Inc. (IEX.H).

What may be a tough call in horseracing is much easier in Canada’s cannabis market. The odds of choosing both the winner and the second-place finisher in any race – an exacta – are never good, but, for Icon Exploration Inc. (TSX.V: IEX.H), the probability of picking winners in Canada’s cannabis market is decidedly better.

Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today announced that more than 20 scientific papers citing the advantages of the Company's pressure cycling technology ("PCT") platform were published by independent researchers worldwide in 2018.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $2.15, off by 0.92%, on 6,129 volume with 10 trades. The average volume for the last 3 months is 4,900 and the stock's 52-week low/high is $1.52/$5.00.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has partnered with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH (http://nnw.fm/5t1JL). The partnership may potentially commercialize this cutting-edge technology for oral nicotine delivery.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.29, off by 3.01%, on 135,266 volume with 156 trades. The average volume for the last 3 months is 180,183 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Smart energy technology company Kontrol Energy (CSE: KNR) (FSE: 1K8) this morning announced that it is targeting a number of strategic and accretive acquisitions as part of its overall growth plans for 2019. To view the full press release, visit: http://nnw.fm/n3dFb.

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.61, off by 1.61%, on 3,000 volume with 1 trade. The average volume for the last 3 months is 20,672 and the stock's 52-week low/high is $0.46/$1.50.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.